Japan Commits To Drug Comparability Protocols As ICH Q12 Takes Shape
This article was originally published in PharmAsia News
In an important advance toward continual improvement of global pharmaceutical manufacturing processes, a Japanese regulatory official has promised that his agency will make it possible to use comparability protocols in Japan.
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
Alkermes CRL is just the latest fallout from black-hole process.
Letter of authorization for COVID-19 therapeutic made at troubled Lilly plant requires independent third-party oversight.